LAB ONE N°1 Butyric Acid 60 Capsules

The dietary supplement LAB ONE N°1 Butyric ACID 60 Capsules is a capsule product containing sodium butyrate or sodium salt, an organic compound that contains a butyric acid residue. Its chemical name is butyric acid.

Butyric acid is produced in the large intestine during the fermentation of sugars by bacteria of the genera Clostridium spp., Eubacterium spp., Fusobacterium spp., etc. The richest sources of butyric acid in the large intestine are resistant starch, oats, and wheat bran. [1]

Butyric acid is an energy source for enterocytes, the normal cells of the intestinal epithelium. Unfortunately, it is supplied in insufficient amounts through food to fulfill this function.

Moreover, this acid helps reduce the severity of diarrhea symptoms caused by various reasons. Additionally, it restores the structural and functional integrity of the intestine and influences the normal motility of the digestive tract. Butyric acid increases the absorption of sodium and thus water in the intestine. It also affects the normalization of the bacterial flora.

Interestingly, butyric acid also accelerates the regeneration of damaged intestinal epithelial cells and has an anti-inflammatory effect by reducing proinflammatory cytokines (IL-6, IL-8, TNF-α) and protects against the leakage of bacteria from the intestine into the bloodstream.

A deficiency of butyric acid in the gastrointestinal tract can lead to mucosal dysfunction in both the small and large intestines. Insufficient concentrations of butyric acid in the intestinal lumen lead to energy deficiency in colonocytes and thus impair epithelial regeneration and the maintenance of epithelial integrity. [2]

In summary, the dietary supplement LAB ONE N°1 Butyric Acid 60 Capsules is a product with a simple composition in a convenient capsule form that provides butyric acid in the form of sodium butyrate, which increases its bioavailability.

1 Kotunia, A., Pietrzak, P., Guilloteau, P., & Zabielski, R. (2010). Butyric acid in the gastrointestinal tract. Prz Gastroenterol, 5, 117-22.

2 Banasiewicz, T., Borycka-Kiciak, K., Dobrowolska-Zachwieja, A., Friediger, J., Kiciak, A., Krokowicz, P., ... & Zabielski, R. (2010). Clinical aspects of the use of butyric acid in the dietary treatment of intestinal diseases . Review of Gastroenterology 2010; 5: 329, 334.

✈️ Express shipping price list (air freight)

📩 Questions? Write to us: kontakt@biogo.de